Elan shares rise on settlement of dispute

Elan shares have risen dramatically, from $4.2 to $ 5.9 over the last week.

Elan has settled its dispute with US pharmaceutical company King which has now agreed to pay around $750m (€634m) to Elan for the US rights to two of Elan's drugs.